Lastly, depressed patients have shown elevated levels of extracellular vesicles containing GFAP or those co-expressing AQP4 and GFAP in serum samples, providing additional evidence for the existence of astrocyte dysfunction in depression [49]. This evidence concerns the gene GFAP and depressive symptom measurement.